Clinical Study
Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies
Table 2
Comparison of the patients’ backgrounds between the success and failure groups, based on PP analysis (third-line eradication therapy).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BMI, body mass index; EM, extensive metabolizer; PM, poor metabolizer; one patient in failure group refused the drug sensitivity test; four patients (three in success group and one in failure group) refused the analysis of CYP2C19 polymorphism; ∗unpaired -test; ∗∗chi-square test. |